Clinical Trials Browser

Phase 1/2 × Recruiting × bicalutamide × Clear all

NCT05095207 2025-04-02

Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer

Phase 1/2 Recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT06222593 2025-02-17

Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination with Sunitinib in Patients with TKIs-resistant RCC

Phase 1/2 Recruiting

Carcinoma, Renal Cell